JH

Jay Harrer

Senior Business Analyst at Be The Match BioTherapies

Jay Harrer is an experienced professional with a strong background in business analysis and project management, currently serving as a Senior Business Analyst at Be The Match BioTherapies since March 2021. Prior experience includes holding the position of Portfolio Manager at Wells Fargo from May 2016 to March 2021 and working at Target from November 1998 to October 2015, where responsibilities included designing technology solutions and managing project deliverables. Earlier roles involved engineering and supporting applications at Electronic Data Systems and customer service management at BI Worldwide. Jay Harrer's career began in the Minnesota National Guard as a Platoon Leader, emphasizing leadership and training. Jay Harrer holds a Bachelor of Arts in Industrial and Organizational Psychology from the University of Minnesota.

Location

Minneapolis, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Be The Match BioTherapies

Be The Match BioTherapies® partners with cell and gene therapy companies to save lives through autologous and allogeneic cellular therapy. We are the only cell and gene therapy solutions provider with customizable services to support the entire end-to-end cell therapy supply chain. As part of the National Marrow Donor Program®(NMDP)/Be The Match®, Be The Match BioTherapies has sourced, collected and delivered cells from more than 100,000 volunteer allogeneic donors around the world for time-critical cellular therapies. We have extensive experience providing cellular source material consented for research, clinical and commercial use. Throughout the past 35+ years, Be The Match BioTherapies has developed and continually enhanced their cell collection network and proven cell therapy supply chain infrastructure. The teams are responsible for more than 6,500 time-sensitive cell therapy shipments per year. Through the CIBMTR® (Center for International Blood and Marrow Transplant Research®), Be The Match BioTherapies provides long-term follow-up tracking for the first two FDA-approved CAR-T therapies. We ask that you please review and follow our Community Guidelines to ensure responsible and respectful conversations: http://bit.ly/2Apu7Ja